Evaluation of Novel Anthelmintic Compounds Against Equine Strongylid Parasites

Grants and Contracts Details

StatusFinished
Effective start/end date5/7/213/31/22

Funding

  • Boehringer Ingelheim Animal Health USA Incorporated: $60,955.00